Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More
- ADVERTISEMENT
-
- Poll of the Day
- Partners
- ADVERTISEMENT
RHHBY
Recent Articles
AstraZeneca Probed Over Heart-Drug Trial
British drug maker AstraZeneca says the U.S. Department of Justice is investigating a clinical trial of its Brilinta heart drug. More
Our Stock Earnings Rundown – HSY KMB DFS SHW LUV TMO AMGN
A big week for earnings and dividend increases includes these 8 stocks in our portfolio. More
Roche’s Breast Cancer Drug Approval Is Just the Beginning
It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape. More
2 Major Pharmaceutical Rivals to Share Drug Data
AstraZeneca and Roche will share drug research data with a third company to build a compound library to accelerate drug development and lower costs. More
Study: New Bird Flu Resistant to Roche’s Tamiflu
Physicians in China have noted that some patients with bird flu are not responding to treatment with Tamiflu, the only known drug used to fight the infection. More
India Drops Patent Bomb on Novartis
India's ruling on a Novartis patent draws a clear line of favor between generic drug companies and Big Pharma. More
